These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36263031)

  • 1. Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity.
    Desikan R; Linderman SL; Davis C; Zarnitsyna VI; Ahmed H; Antia R
    Front Immunol; 2022; 13():985478. PubMed ID: 36263031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
    Dulin H; Barre RS; Xu D; Neal A; Vizcarra E; Chavez J; Ulu A; Yang M-S; Khan SR; Wuang K; Bhakta N; Chea C; Wilson EH; Martinez-Sobrido L; Hai R
    J Virol; 2024 Feb; 98(2):e0157123. PubMed ID: 38206036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Vaccine Strain Selection: Guidance From Influenza.
    Monto AS; Lauring AS; Martin ET
    J Infect Dis; 2022 Dec; 227(1):4-8. PubMed ID: 36424890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling suggests that multiple immunizations or infections will reveal the benefits of updating SARS-CoV-2 vaccines.
    Desikan R; Linderman SL; Davis C; Zarnitsyna V; Ahmed H; Antia R
    bioRxiv; 2022 May; ():. PubMed ID: 35665010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection.
    Huang Y; Shi H; Forgacs D; Ross TM
    Vaccine; 2024 Feb; 42(5):1184-1192. PubMed ID: 38296701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    Chaparian RR; Harding AT; Hamele CE; Riebe K; Karlsson A; Sempowski GD; Heaton NS; Heaton BE
    J Virol; 2022 Aug; 96(15):e0068922. PubMed ID: 35862698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge.
    Hill-Batorski L; Bowen R; Bielefeldt-Ohmann H; Moser MJ; Matejka SM; Marshall D; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2024 Apr; 42(11):2770-2780. PubMed ID: 38508930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
    J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity.
    Tejedor Vaquero S; de Campos-Mata L; Ramada JM; Díaz P; Navarro-Barriuso J; Ribas-Llaurado C; Rodrigo Melero N; Carolis C; Cerutti A; Gimeno R; Magri G
    Front Immunol; 2021; 12():737083. PubMed ID: 34539673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB/c mice.
    Zhang N; Ye Z; Li C; Zhou J; Xue W; Xiang L; Chen Y; Chen S; Ye R; Dong J; Zhou J; Jiang S; Han H
    J Med Virol; 2024 Mar; 96(3):e29479. PubMed ID: 38425270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter- and intra-individual differences regarding SARS-CoV-2 and influenza vaccination in pediatric kidney transplant recipients: An observational study.
    Kanai T; Ito T; Saito T; Aoyagi J; Kurosaki M; Betsui H; Maru T; Ono M; Tajima T
    Medicine (Baltimore); 2024 Jul; 103(27):e38809. PubMed ID: 38968522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
    Bricker TL; Joshi A; Soudani N; Scheaffer SM; Patel N; Guebre-Xabier M; Smith G; Diamond MS; Boon ACM
    J Virol; 2024 Mar; 98(3):e0120623. PubMed ID: 38305154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.
    Shi R; Zeng J; Xu L; Wang F; Duan X; Wang Y; Wu Z; Yu D; Huang Q; Yao YG; Yan J
    EBioMedicine; 2022 Nov; 85():104297. PubMed ID: 36206623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Virus and SARS-CoV-2 Vaccines.
    Sandor AM; Sturdivant MS; Ting JPY
    J Immunol; 2021 Jun; 206(11):2509-2520. PubMed ID: 34021048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies.
    Abd Alhadi M; Friedman LM; Karlsson EA; Cohen-Lavi L; Burkovitz A; Schultz-Cherry S; Noah TL; Weir SS; Shulman LM; Beck MA; Hertz T
    Microbiol Spectr; 2023 Jun; 11(3):e0001023. PubMed ID: 37098954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccinations in pulmonary diseases - part 1: Covid and influenza].
    Kodde C; Sander LE
    Dtsch Med Wochenschr; 2024 Aug; 149(17):1045-1049. PubMed ID: 39146753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.